The PE Ratio as of November 2024 (TTM) for Salarius Pharmaceuticals, Inc. (SLRX) is -0.27

According to Salarius Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.27. This represents a change of -84.15% compared to the average of -1.70 of the last 4 quarters.

Salarius Pharmaceuticals, Inc. (SLRX) Historical PE Ratio (quarterly & annually)

How has SLRX PE Ratio performed in the past?

The mean historical PE Ratio of Salarius Pharmaceuticals, Inc. over the last ten years is -148.23. The current -0.27 PE Ratio has changed -81.78% with respect to the historical average. Over the past ten years (40 quarters), SLRX's PE Ratio was at its highest in in the June 2024 quarter at -0.23. The PE Ratio was at its lowest in in the December 2014 quarter at -136.00.

Salarius Pharmaceuticals, Inc. (SLRX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Salarius Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Salarius Pharmaceuticals, Inc. (SLRX) Average PE Ratio

How has SLRX PE Ratio performed in the past?

The current PE Ratio of Salarius Pharmaceuticals, Inc. (SLRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Salarius Pharmaceuticals, Inc. (SLRX) PE Ratio vs. Peers

How is SLRX’s PE Ratio compared to its peers?

Salarius Pharmaceuticals, Inc.’s PE Ratio is greater than Akari Therapeutics, Plc (-0.81), greater than Axcella Health Inc. (-3.07), less than Magenta Therapeutics, Inc. (-0.15), less than Histogen Inc. (-0.01), less than Timber Pharmaceuticals, Inc. (-0.04), greater than Artelo Biosciences, Inc. (-0.81), greater than Nutriband Inc. (-7.34), greater than Aileron Therapeutics, Inc. (-1.83), greater than First Wave BioPharma, Inc. (-0.85), greater than SAB Biotherapeutics, Inc. (-0.64), greater than Vaccinex, Inc. (-0.39), greater than GeoVax Labs, Inc. (-0.78), greater than Corvus Pharmaceuticals, Inc. (-10.50), greater than Mereo BioPharma Group plc (-13.56), greater than Affimed N.V. (-0.54), greater than Pieris Pharmaceuticals, Inc. (-1.39), greater than Artelo Biosciences, Inc. (-0.81), greater than Fresh Tracks Therapeutics, Inc. (-3.00),

Build a custom stock screener for Salarius Pharmaceuticals, Inc. (SLRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Salarius Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Salarius Pharmaceuticals, Inc. (SLRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Salarius Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.